Background: PLC-b signaling is generally thought to be mediated by allosteric activation by G proteins and Ca 2+ . Although availability of the phosphatidylinositol-4,5-biphosphate (PIP 2 ) substrate is limiting in some cases, its production has not been shown to be independently regulated as a signaling mechanism. WNK1 protein kinase is known to regulate ion homeostasis and cause hypertension when expression is increased by gene mutations. However, its signaling functions remain largely elusive. Results: Using diacylglycerol-stimulated TRPC6 and inositol trisphosphate-mediated Ca 2+ transients as cellular biosensors, we show that WNK1 stimulates PLC-b signaling in cells by promoting the synthesis of PIP 2 via stimulation of phosphatidylinositol 4-kinase IIIa. WNK1 kinase activity is not required. Stimulation of PLC-b by WNK1 and by Ga q are synergistic; WNK1 activity is essential for regulation of PLC-b signaling by G q -coupled receptors, and basal input from G q is necessary for WNK1 signaling via PLC-b. WNK1 further amplifies PLC-b signaling when it is phosphorylated by Akt kinase in response to insulin-like growth factor. Conclusions: WNK1 is a novel regulator of PLC-b that acts by controlling substrate availability. WNK1 thereby coordinates signaling between G protein and Akt kinase pathways. Because PIP 2 is itself a signaling molecule, regulation of PIP 2 synthesis by WNK1 also allows the cell to initiate PLC signaling while independently controlling the effects of PIP 2 on other targets. These findings describe a new signaling pathway for Akt-activating growth factors, a mechanism for G proteingrowth factor crosstalk, and a means to independently control PLC signaling and PIP 2 availability.
Introduction
Mammalian WNK kinases are a family of four serine-threonine protein kinases with an atypical kinase active site [1] [2] [3] . Mutations in WNK1 and WNK4 cause the autosomal-dominant disease pseudohypoaldosteronism type 2 (PHA2), which is characterized by hypertension and hyperkalemia [2] . WNKs regulate various ion transporters through both kinase activity-dependent and -independent mechanisms [3, 4] . For example, WNK1 and WNK4 phosphorylate and activate Ste20-related proline-alanine-rich kinase (SPAK) and oxidative stress-responsive kinase-1 (OSR1), which in turn activate cation-chloride cotransporters NCC and NKCC [5] [6] [7] . Through kinase-independent events, WNK1 binds and somehow activates SGK kinase, causing it to activate the epithelial Na + channel ENaC [8] ; and WNK1 and WNK4 interact with the endocytic scaffold protein intersectin to enhance endocytosis of the renal K + channel ROMK [9] . Dysregulation of ion transport in the kidney contributes to the hypertension and hyperkalemia of PHA2.
The functions of WNKs extend beyond regulation of ion homeostasis. WNK1 is ubiquitously expressed, and homozygous gene inactivation in mice causes cardiovascular developmental arrest and embryonic death [10] . WNK1 activates ERK5, and knockdown of WNK1 decreases activation of ERK5 by epidermal growth factor receptors [11] . WNK2 binds the small GTPases RhoA and Rac1. WNK2 knockdown decreases RhoA activation but promotes Rac1 activation [12] . The G q -coupled angiotensin II receptor regulates the activity of the NCC cotransporter through the WNK4 signaling pathway [13] , indicating functional interactions between WNK and G protein signaling pathways.
Upstream regulation of the WNKs is incompletely understood, and it is likely that several distinct mechanisms of WNK activation are used in different cells [3, 4] . WNK1 is a substrate of Akt kinase [14, 15] , which is a target of phosphatidylinositol 3-kinase (PI3K)-activating growth factors such as insulin and insulin-like growth factors (IGFs). Insulin and IGFs activate PI3K and its phosphatidylinositol-1,4,5-triphosphate (PIP 3 ) product recruits and activates Akt to phosphorylate WNK1 at threonine-58. It has been reported that Akt-catalyzed phosphorylation of WNK1 at T58 alters the ability of WNK1 to regulate membrane trafficking of ENaC and ROMK channels [8, 16] .
Phospholipase C-bs (PLC-bs) are important effectors of G protein-coupled receptor (GPCR)-mediated signaling pathways [17, 18] . They hydrolyze phosphatidylinositol-4,5-biphosphate (PIP 2 ), itself a signaling molecule, to form two other second messengers, diacylglycerol (DAG) and inositol-1,4,5-trisphosphate (IP 3 ). PLC-bs are stimulated by Ga subunits of the G q family, by Gbg subunits of the G i s, and, in the case of PLC-b2, by Rac [17] [18] [19] . The concentration of PIP 2 in the plasma membrane is limiting for PLC-b activity, and resynthesis of the substrate initiated by phosphatidylinositol-4-kinase (PI4K) after depletion is important for sustained PLC-b signaling [20, 21] . This dependence on substrate concentration agrees with in vitro studies showing that PLC activity increases linearly with the concentration of PIP 2 regardless of stimulation by G proteins or Ca 2+ [22, 23] . However, it is not known whether PIP 2 production can be independently regulated as a signaling mechanism and, if so, by what physiological stimulus.
We show here that WNK1 stimulates PLC-b signaling by promoting the synthesis of PIP 2 via stimulation of PI4KIIIa. Stimulation of PLC-b by WNK1 and by Ga q -GTP is thus synergistic, and WNK1 activity is essential for regulation of PLC-b signaling by G q -coupled receptors. Phosphorylation of WNK1 by the PI3K-Akt kinase cascade enhances the ability of WNK1 to synergistically regulate PLC-b signaling via synthesis of PIP 2 . Regulated control of substrate availability represents a novel mechanism for regulation of PLC-b activity and for crosstalk between G q -coupled receptors and receptors that activate the Akt kinase pathway.
Results

WNK1 Activates TRPC6 Channels
The TRPC6 channel is directly activated by DAG, a product of the PLC-catalyzed hydrolysis of PIP 2 [24] . Inspired by a serendipitous observation that WNK1 knockdown altered G q signaling, we used TRPC6 as a biosensor to examine the role of WNK1 in PLC-b signaling in native cell membranes. Full-length WNK1 is difficult to purify, and we tested the effect of WNK1 on TRPC6 by intracellular application of a purified fragment of rat WNK1 consisting of residues 1-491 (WNK1 ), which contains the Akt-phosphorylation site, the protein kinase domain, and an N-terminal proline-rich domain ( Figure 1A ). As shown for HEK293 cells in Figure 1B , intracellular WNK1 1-491 increased TRPC6 current density, peaking in these cells at around 1-2 min and lasting for >5 min. The half-maximal concentration of WNK1 1-491 for activation of TRPC6 was w50 nM ( Figure 1C ). WNK1 1-491 also activates TRPC6 in membranes of HeLa cells (see Figure 6) and mouse embryo fibroblasts (see Figures 2C and  2D ). TRPC6 was also activated by GTPgS, consistent with G q -PLC-b signaling to produce DAG, and by the muscarinic agonist carbachol in cells that express the G q -coupled M3 muscarinic cholinergic receptor ( Figure 1B) .
Application of WNK1 to the cytoplasmic face of detached plasma membranes also activated TRPC6 single channel activity in membranes of cells that express TRPC6 (see Figure S1A available online) but not in membranes from control cells. Thus, the cellular components required for activation of TRPC6 by WNK1 are contained in or are bound to the excised plasma membrane patch. Stimulation of TRPC6 was selectively blocked by antibody against amino acid residues 160-176 of WNK1 ( Figure S1B ). Purified WNK1 carrying a kinase-dead K233M mutation [1, 9] retained full ability to activate TRPC6 ( Figure S1C ), indicating that kinase activity of WNK1 is dispensable.
Activation of TRPC6 by WNK1 Requires PLC Activity Several experimental results argue that the activation of TRPC6 by WNK1 is mediated by PLC-b-catalyzed production of the known TRPC6 activator DAG. First, activation of TRPC6 by WNK1 was blocked by the PLC inhibitors U73122 ( Figure 1D ) and edelfosine [25] (Figure 1E ). Application of 1-oleoyl-2-acetyl glycerol (OAG), a soluble and membranepermeant DAG, restored TRPC6 activity in the continued presence of U73122, which excludes effects of U73122 on the channel itself or on other components upstream of PLC. Second, because edelfosine acts slowly [25] , we could rescue WNK1 signaling by addition of purified PLC-b1 after endogenous PLC was inhibited ( Figure 1E ). After edelfosine pretreatment, application of both purified PLC-b1 and WNK1 caused robust activation of TRPC6. Application of PLC-b1 without WNK1 had no effect, indicating that both WNK1 and PLC-b1 are required for activation of TRPC6. Third, PLC activity is dependent on cytosolic Ca 2+ [17, 18] , and removal of Ca 2+ blocked TRPC6 stimulation by WNK1 1-491 , but not direct stimulation by OAG ( Figure 1F ). Based only on the data above, WNK1 1-491 might activate TRPC6 by protecting DAG from hydrolysis by DAG lipase or phosphorylation by DAG kinase. However WNK1 did not alter the potency with which OAG activates TRPC6 ( Figure 1G ), indicating that its effect is at the level of PLC. Together, these results provide compelling evidence that WNK1 activates TRPC6 by stimulation of PLC to produce DAG, the proximal activator.
We also measured intracellular Ca 2+ release triggered by IP 3 , another product of PIP 2 hydrolysis, as a readout for WNK1's effects on PLC activity. Microinjection of anti-WNK1 antibody or knocking down endogenous WNK1 by small interfering . OAG was applied to the extracellular solution at indicated concentrations. Although this concentration of WNK1 1-491 by itself does not activate TRPC6, it potentiated M3R activation of the channel (see Figure 3B ; Figure S1 ).
RNA (siRNA) reduced the intracellular Ca
2+ increases in response to carbachol (Figures S1D-S1F). Endogenous WNK1 is thus required for normal PLC-b signaling in response to stimulation of G q .
WNK1 Works in Parallel with G q to Synergistically Stimulate TRPC6
The PLC-bs are activated by Ga q [17, 18] . GDPbS, which blocks G protein activation, inhibited the stimulation of TRPC6 by WNK1 (Figure 2A ). GTPgS stimulated the TRPC6 current without added WNK1, and stimulation was blocked by anti-WNK1 antibody ( Figure 2B ; Figures S2A and S2B). These data suggest both that some G protein is required for WNK1 stimulation of TRPC6 and that endogenous WNK1 is required for TRPC6 stimulation by a G (D) Single channel activity was measured in inside-out patches from TRPC6-expressing Ga q/11 null fibroblasts that have endogenous WNK1 depleted by small interfering (siRNA). Data show responses to GTPgS-preactivated Ga q (Ga q *) and/or WNK1 applied to the cytoplasmic face. Holding membrane potential is 280 mV. Inset shows mean 6 SEM of peak open probability. *p < 0.01 versus buffer, **p < 0.05 versus buffer, and ***p < 0.02 between indicated groups. (E and F) Single channel activity was recorded in insideout patches from HEK cells expressing both TRPC6 and wild-type Ga q (Ga q /WT) (E) or G188S mutant Ga q (Ga q / G188S) (F). Buffer, WNK1 , and/or RGS4 (0.5 mM) was applied to the cytoplasmic face as indicated. NPo values were averaged every 20 s. There was a 2 min time gap between application of buffer and WNK1 (see also Figure S2 ).
protein. To determine whether WNK1 requires activation of PLC-b by G q/11 in cells, we measured TRPC6 regulation by WNK1 in murine Ga q 2/2 -Ga 11 2/2 embryonic fibroblasts [26] . In intact Ga q/11 null cells, WNK1 failed to activate TRPC6, and expression of wild-type Ga q restored activation by WNK1 ( Figure 2C ). When the constitutively active Q209L-Ga q mutant was expressed, addition of WNK1 1-491 further activated TRPC6 ( Figures S2C and  S2D ), which argues that WNK1 and Ga q act in parallel rather than in series to stimulate DAG synthesis by PLC-b.
When WNK1 was depleted in the Ga q/11 null cells by siRNA, neither WNK1 1-491 nor Ga q -GTPgS alone stimulated TRPC6 substantially, only simultaneous addition of both activators produced major TRPC6 opening ( Figure 2D) . Moreover, the G q inhibitor RGS4 blocked activation of TRPC6 by WNK1 in cells and the N128G mutant of RGS4 [27] had no effect ( Figures  S2E and S2F) . In detached patches, inhibition by RGS4 was reduced and delayed by expression of the RGS-insensitive G188S mutant of Ga q [28, 29] (Figures 2E and 2F) . Thus, WNK1 and activated Ga q stimulate TRPC6 synergistically. (B) Whole-cell CCh-induced TRPC6 currents were recorded in the presence of control buffer or WNK1 1-491 (3 nM), a concentration that does not appreciably stimulate TRPC6 by itself. *p < 0.01 for WNK1 versus buffer (see also Figure S3 ).
WNK1 Activity Is Necessary for Activation of TRPC6
by G q -Coupled Receptors Intracellular application of anti-WNK1 antibody markedly blunted the activation of TRPC6 by agonist through the expressed M3 muscarinic receptor ( Figure 3A) , the a 1A -, a 1B -adrenergic receptors, and H1 histaminergic receptor in HEK cells ( Figures S3A-S3C ) or through endogenous muscarinic receptor in HeLa cells ( Figure S3D) . Conversely, increased WNK1 activity potentiated activation of TRPC6 by M3 receptor. Intracellular application of 3 nM WNK1 1-491, which is too low to activate TRPC6 by itself, approximately doubled the TRPC6 current elicited by M3 muscarinic stimulation (Figure 3B) . Thus, some level of endogenous WNK1 activity is necessary for full G q -PLC-b signaling and additional WNK1 potentiates G q signaling in cells.
Anti-WNK1 antibody did not significantly inhibit activation of TRPC6 by the G i -coupled M2 muscarinic receptor (Figure S3E) . However, G i is a less effective activator of PLC-bs [17, 18] , and TRPC6 activation by the M2 receptor is much smaller than that by the G q -coupled receptors ( Figure S3E versus Figure 3A) . This apparent selectivity of anti-WNK1 antibody for G q -coupled receptors suggests that WNK1 is needed to support the higher flux of the G q -PLC-b pathway but is not detectably required for G i -PLC-b signaling.
Although these data are consistent with the stimulation of PLC-b activity by WNK1, we did not find any effect of purified WNK1 1-491 on the activity of purified PLC-b1, 2, or 3; its regulation by Ga q or Gbg; or regulation of G q by M1 muscarinic receptors ( Figure S4 ).
Activation of TRPC6 by WNK1 via PI4K-Mediated PIP 2 Synthesis
The interdependence and mutual potentiation of TRPC6 activation by the Ga q and WNK1 pathways suggests that they each increase the activity of PLC-b by distinct mechanisms. Ga q allosterically stimulates the catalytic activity of PLC-b. We therefore asked whether WNK1 acts by increasing the concentration of the PIP 2 substrate. Generation of phosphatidylinositol 4-P (PI4P) by PI4K is believed to be the first step in the synthesis of PIP 2 [30] . Pretreatment of cells with the PI4K inhibitor wortmannin inhibited activation of TRPC6 by WNK1 (Figure 4A ) as did simultaneous application of an anti-PI4P antibody [31] (Figure 4B ). Last, intracellular application of PI4KIIIb activated TRPC6 even in the absence of added WNK1, and pretreatment with wortmannin prevented activation ( Figure 4C ). PI4P synthesis is thus involved in the stimulation of TRPC6 by WNK1, and WNK1 can be mimicked by addition of a PI4K.
We used the GFP-tagged pleckstrin homology (PH) domain of PLC-d1 and confocal imaging to examine the role of WNK1 in the degradation and resynthesis of PIP 2 in the plasma membrane. The PLC-d1-PH domain binds both PIP 2 and IP 3 with relatively high affinity and specificity [32] [33] [34] . In cells that express M3 receptor, addition of carbachol decreased GFP-PLC-d1-PH fluorescence at the plasma membrane, indicating reduced PIP 2 and increased fluorescence in the cytosol, indicating increased IP 3 ( Figure 5 ). Both effects peak w45 s after carbachol addition and then decline to prestimulus levels, reflecting PLC-b-catalyzed hydrolysis of PIP 2 and its subsequent resynthesis.
Microinjection of anti-WNK1 antibody both delayed and decreased the recovery of GFP-PLC-d1-PH fluorescence at the plasma membrane after treatment with carbachol. Instead of the monophasic return to baseline in <3 min observed in control cells, cells treated with anti-WNK1 antibody displayed biphasic recovery of plasma membrane fluorescence that was only w50% complete after 15 min. The return of cytosolic fluorescence to baseline was also biphasic, with a greatly prolonged and incomplete second phase. These data indicate that anti-WNK1 antibody substantially inhibits resynthesis of PIP 2 after a burst of PLC activity. Taken together with the effects of the anti-PI4P antibody, they indicate that WNK1 is necessary to maintain cellular PIP 2 synthesis. (C) Whole-cell TRPC6 current in response to intracellular delivery of 100 nM PI4KIIIb preincubated with or without 10 mM wortmannin for 10 min. *p < 0.01 for vehicle versus wortmannin. Note that both type IIIa and IIIb PI4K can generate PI4P for synthesis of phosphatidylinositol 4,5-biphosphate (PIP 2 ) in the membrane. Due to difficulties in purification of PI4KIIIa, we used only PI4KIIIb for experiments here. In all panels, data point is mean 6 SEM of inward current density, n = 5-9 for each condition (see also Figure S4 ).
WNK1 Potentiates PI4P Synthesis by PI4KIIIa
The PI4KIIIa isozyme is believed to be primarily responsible for resynthesis of PIP 2 in the plasma membrane during receptor stimulation of PLC [30] . To determine whether WNK1 regulates PI4KIIIa, we studied effects of manipulating WNK1 activity in cells that express recombinant PI4KIIIa, where this isoform is the predominant PI4K activity (w95%) in a light membrane fraction, which includes plasma membranes ( Figure 6A ). Knockdown of WNK1 by siRNA decreased both PI4K activity and the amount of immunoreactive PI4KIIIa in the light membrane fraction by 35%-40% (Figures 6B-6E ) and increased the abundance of PI4KIIIa in cytosol ( Figures  6D and 6E ). WNK1 knockdown did not alter the amount of PI4KIIIa in the total postnuclear supernatant (PNS). These data suggest that WNK1 recruits PI4KIIIa from cytosol to the light membrane fraction, presumably the plasma membrane. Recruitment may be indirect, because we did not detect physical association between PI4KIIIa and purified WNK1 1-491 in pull-down assays.
WNK1 failed to activate TRPC6 in PI4KIIIa-knockdown cells ( Figures 6F and 6G ) and expression of PI4KIIIa in the knockdown cells rescued activation by WNK1. These results are consistent with the idea that WNK1 increases PIP 2 synthesis by recruitment of PI4KIIIa to its site of action and that the consequently increased availability of PIP 2 synergistically enhances G q -coupled receptor signaling through PLC-b.
IGF1 Potentiates G q -PLC-b Signaling via PI3K and Akt-Mediated Phosphorylation of WNK1
The physiological role of WNK1 in the regulation of G q -PLC-b signaling was further supported by the finding that IGF1, a known upstream activator of WNK1, enhances the effect of WNK1. Pretreatment with IGF1 in serum-starved cells potentiated the activation of TRPC6 by either carbachol (Figures 7A  and 7B ) or GTPgS ( Figures S5A and S5B) , although IGF1 did not alter basal TRPC6 current. Lack of effect on the basal current is probably due to a low basal output from G q -PLC-b in serum-starved cells, and IGF1 activated TRPC6 in these cells when prestimulated by GTPgS ( Figure S5C ). IGF1 also enhanced carbachol-induced intracellular Ca 2+ transients ( Figure S5D ), consistent with a final common site of action at PLC-b. IGF1 did not increase the cell-surface abundance of TRPC6 ( Figure S5E ).
Several observations argue that IGF1 potentiates GPCR-G q signaling through a PI3K-Akt-WNK1-PI4KIIIa sequence. First, wortmannin, at a low concentration selective for PI3K (20 nM) , blocked the effect of IGF1 on G q signaling. Knockdown of WNK1 also blocked the ability of IGF1 to potentiate carbachol's effect ( Figure 7C ). Expression of wild-type WNK1, but not the T58A mutant WNK1, restored the ability of IGF1 to enhance carbachol activation of TRPC6 in WNK1-knockdown cells (Figure 7D ), indicating that the synergistic effect of IGF1 and M3 muscarinic stimulation depends on Akt-mediated phosphorylation of WNK1 at T58. Note that both wild-type WNK1 and the T58A mutant can support carbachol activation of TRPC6 in WNK1-knockdown cells. Thus, T58-phosphorylation is not required for WNK1 amplification of G q -PLC-b signaling, but is indispensable for its potentiation by IGF1.
Knockdown of PI4KIIIa also prevented enhancement of carbachol activation of TRPC6 and intracellular Ca 2+ transients by IGF1 ( Figure 7E ; Figure S5F ). These results argue that PI3K-dependent activation of Akt by IGF1 leads to phosphorylation of WNK1 and enhances the ability of WNK1 to synergistically regulate PLC-b signaling by promoting PIP 2 synthesis.
Discussion
Our data establish three new and distinct but interrelated signaling mechanisms: the mutual dependence and synergistic interaction between the G q -PLC-b and Akt-WNK1 signaling pathways, the regulation of PLC-b activity by modulating the availability of its substrate, and the regulation of PI4KIIIa by WNK1 to control the concentration of PIP 2 -derived second messengers.
As summarized in Figure 7F , blocking WNK1 activity markedly inhibits PLC-b signaling by G q -coupled receptors and, conversely, inhibiting G q blocks PLC-b signaling by WNK1. Inhibition could be exerted by several approaches and at several steps in each pathway, both in cells and in detached membrane patches. In each case, replenishment of the inhibited or depleted species, or stimulation of a downstream component, restored normal activities of both WNK1 and G q -PLC-b. Importantly, WNK1 can elicit PLC signals without added GPCR agonist, and WNK1 synergistically amplifies the stimulation of PLC-b by G q .
In contrast to G proteins, WNK1 increases PLC-b activity by increasing the supply of the PIP 2 substrate. Because the concentration of PIP 2 in the plasma membrane is below K m [22, 23] , PLC-b displays first-order substrate kinetics and increase in available PIP 2 linearly amplifies PLC-b output. Note that WNK1 only modulates G q signaling via PLC-b. Other outputs, such as stimulation of a rho guanine nucleotide exchange factor [35] , are not involved. WNK1 thus alters the spectrum of G q outputs as well as its amplitude.
WNK1 promotes synthesis of PIP 2 by somehow activating PI4KIIIa ( Figure 6 ; Figure 7F ). PI4KIIIa is important for the resynthesis of PIP 2 following hydrolysis by receptor-stimulated PLC [30] , but how the activity of PI4KIIIa is regulated is unknown. The amount of PI4KIIIa is decreased in membranes from WNK1 knockdown cells, suggesting that regulation of PI4KIIIa by WNK1 may involve its redistribution between plasma membrane and intracellular pools. However, WNK1 must do more than just recruit PI4KIIIa to the plasma membrane because it remains necessary for PLC-b signaling in detached patches. We have no evidence that WNK1 either binds or phosphorylates PI4KIIIa, and additional factors may be involved.
Regardless, our results indicate that the activity of PI4KIIIa is regulated and that its regulation by WNK1 is critical for PLC-b signaling by G q -coupled receptors. The basal activity of WNK1 provides adequate tonic stimulation of PI4KIIIa to provide PIP 2 for normal PLC-b signaling. However, additional WNK1 markedly amplifies signaling by G q -coupled receptor even at a concentration that does not by itself activate TRPC6 ( Figure 3B ). In addition, PI3K-activating growth factors such as IGF1 activate WNK1 to further potentiate G q -PLC-b signaling, probably via Akt-mediated phosphorylation of WNK1 at T58 (Figure 7) . These results suggest that WNK1 is an important physiological mediator of the Akt kinase signaling pathway and coordinates Akt signaling with the G q -PLC-b signaling pathway.
This action of WNK1 represents the first known instance of acute control of PIP 2 availability as a mechanism of regulation of cellular DAG and IP 3 concentrations without concurrent stimulation of the intrinsic activity of PLC. Application of WNK1 alone stimulates the production of DAG measured using the TRPC6 biosensor by an amount comparable to that initiated by GTPgS ( Figure 1B) . Some low output of PLC-b, evidently dependent on basal input from Ga q , is adequate to support this WNK1 signaling. By promoting PIP 2 synthesis, WNK1 can also acutely modulate the amplitude of receptor-stimulated PLC-b signaling and/or its duration. Inhibition of endogenous WNK1 by anti-WNK1 antibody blocks both the DAG and IP 3 limbs of PLC-b signaling stimulated by multiple G q -coupled receptors by R50% ( Figure 3A ; Figures S1D-S1F; Figure S3 ). Acute stimulation of WNK1 activity by IGF1 potentiates PLC-b signaling by w2-fold ( Figures 7A and  7B ). WNK1 thus controls a major mode of desensitization of G q signaling in addition to modulating acute responses. PIP 2 itself is a signaling molecule that regulates many plasma membrane targets [36] . Increasing PIP 2 synthesis by WNK1 is thus an important mechanism for increasing cellular DAG and IP 3 concentrations without causing untoward effects of decreases in membrane PIP 2 on other targets.
PLC-b enzymes function as coincidence detectors that synergistically integrate multiple upstream inputs including Ga q , Gbg, Ca
2+
, and Rac [37, 38, 39] . These mechanisms of synergism are results of combined superadditive stimulation of the catalytic activity of PLC-b. In contrast, synergism between WNK1 and Ga q depends on the ability of WNK1 to enhance substrate supply for PLC-b. This system is analogous to the interaction between PLCs and inositol phosphate kinases in which PLC provides the IP 3 starting material that the cell-type-specific kinases then phosphorylate to the appropriate inositol polyphosphates [40] .
The interactive control of PLC-b by WNK and G q may have important implications in the pathogenesis of hypertension in patients with PHA2 that is caused by mutations of WNK1 that increase WNK1 expression [2] . G q/11 -mediated PLC-b signaling plays a central role in the regulation of vascular The experimental results indicate that the point at which G q and WNK1 interact is at the level of PLC activity (marked by dark green box) (see also Figure S5 ).
tone by virtually all vasoactive hormones [41] , and potentiation of PLC-b signaling by WNK1 would promote vasoconstriction and cause hypertension. The role of WNK1 in the regulation of vascular tone is supported by the report that mice with heterozygous inactivation of Wnk1 display reduced blood pressure without renal Na + wasting and hypovolemia [42] . Finally, the similarity between the phenotypes of WNK1-knockout and Ga q /Ga 11 -knockout mice (both lethal at embryonic day w10.5, with cardiac defects) supports the idea that interaction between the WNK1 and Ga q/11 pathways is important for embryonic development [10, 26] .
In conclusion, WNK1 potentiates G q -PLC-b signaling by stimulating the activity of PI4KIIIa to increase synthesis of PIP 2 . Phosphorylation of WNK1 by Akt kinase increases its activity in this pathway and allows tyrosine kinase receptors or other activators of the Akt kinase cascade to regulate G protein-mediated PLC-b signaling. The extent and physiological role of WNK1 in the regulation of PLC-b signaling will probably differ among specialized cells. Our understanding of these interactions should expand as we learn more ways in which WNK1 activity is regulated.
Experimental Procedures
Detailed experimental procedures are in the Supplemental Information. HEK293 and HeLa cells and mouse embryonic fibroblasts were cultured and cotransfected with complementary DNAs (cDNAs) for TRPC6-Flag with or without human M3 muscarinic receptor [43] . Ruptured whole-cell, cell-attached, and inside-out excised patch-clamp recording were performed as described [9, 43] . Intracellular Ca 2+ transients were examined using ratiometric fluorescent Ca 2+ images of fura-2-loaded cells. PIP 2 and IP 3 were localized according to fluorescence of a GFP-tagged PLC-d1-PH domain by confocal microscopy [34] . PLC activity was measured by monitoring hydrolysis of [ 3 H]PIP 2 on large unilamellar phospholipid vesicles [22, 37] . PI4KIIIa activity from HeLa cells was measured by phosphorylation of phosphatidylinositol (PI) in PI/Triton X-100-mixed micelles [44] .
Supplemental Information
Supplemental Information includes five figures and Supplemental Experimental Procedures and can be found with this article online at doi:10.1016/ j.cub.2011.11.002.
